This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Teijin Pharma Limited. Active years: 2015-2018.
Company Filing History:
Years Active: 2015-2018
Title: Junji Igarashi: Innovator in Pharmaceutical Compounds
Introduction
Junji Igarashi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with therapeutic applications. With a total of 2 patents, Igarashi's work focuses on innovative solutions to medical challenges.
Latest Patents
Igarashi's latest patents include a Pyrido[3,4-d]pyrimidine derivative and pharmaceutically acceptable salt thereof. The purpose of this invention is to provide a compound that exhibits excellent CDK4/6 inhibiting activity. This compound is represented by a specific general formula, which highlights its potential in cancer treatment. Another notable patent involves quaternary ammonium salt compounds. The objective of this invention is to introduce a novel compound that possesses both β2 adrenergic receptor agonist activity and muscarinic receptor antagonist activity. This dual functionality could lead to advancements in respiratory therapies.
Career Highlights
Igarashi is currently associated with Teijin Pharma Limited, where he continues to push the boundaries of pharmaceutical research. His work is characterized by a commitment to developing innovative compounds that address unmet medical needs.
Collaborations
Igarashi collaborates with esteemed colleagues, including Etsuko Mitsuyama and Takayuki Hara. Their combined expertise enhances the research and development efforts at Teijin Pharma Limited.
Conclusion
Junji Igarashi's contributions to pharmaceutical innovation are noteworthy, particularly in the development of compounds with significant therapeutic potential. His work exemplifies the impact of dedicated research in improving healthcare outcomes.